Compare AMPH & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | UDMY |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2014 | 2021 |
| Metric | AMPH | UDMY |
|---|---|---|
| Price | $27.12 | $5.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $31.00 | $9.00 |
| AVG Volume (30 Days) | 389.3K | ★ 4.0M |
| Earning Date | 11-06-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.27 | N/A |
| Revenue | $723,305,000.00 | ★ $795,801,000.00 |
| Revenue This Year | $1.35 | $2.34 |
| Revenue Next Year | $5.10 | $2.66 |
| P/E Ratio | $11.87 | ★ N/A |
| Revenue Growth | N/A | ★ 2.53 |
| 52 Week Low | $20.39 | $4.86 |
| 52 Week High | $39.56 | $10.61 |
| Indicator | AMPH | UDMY |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 58.46 |
| Support Level | $26.26 | $5.77 |
| Resistance Level | $27.44 | $7.16 |
| Average True Range (ATR) | 0.82 | 0.33 |
| MACD | 0.06 | 0.08 |
| Stochastic Oscillator | 83.33 | 38.00 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.